共 137 条
[1]
Tarride JE(2012)The burden of illness of osteoporosis in Canada Osteoporos Int 23 2591-2600
[2]
Hopkins RB(2007)A systematic review of persistence and compliance with bisphosphonates for osteoporosis Osteoporos Int 18 1023-1031
[3]
Leslie WD(2012)The clinical and economic burden of poor adherence and persistence with osteoporosis medications in Ireland Value Health 15 604-612
[4]
Cramer J a(2008)Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization Osteoporos Int 19 1421-1429
[5]
Gold DT(2013)Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group Osteoporos Int 24 2907-2918
[6]
Silverman SL(2013)Shared decision making to improve care and reduce costs New Engl J Med 368 6-8
[7]
Lewiecki EM(2014)The cost-effectiveness of patient decision aids: a systematic review Healthcare 2 251-257
[8]
Hiligsmann M(2011)Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial Am J Med 124 549-556
[9]
McGowan B(2011)Cost effectiveness of denosumab compared with oral bisphosphonates in the treatment of post-menopausal osteoporotic women in Belgium Pharmacoeconomics 29 895-911
[10]
Bennett K(2009)Development and validation of a markov microsimulation model for the economic evaluation of treatments in osteoporosis Value Health 12 687-696